Use of alpha-rar antagonists for inhibition of mucin secretion
CA 2321935 A1 · Owner: Belloni, Paula Nanette · Inventors: Belloni, Paula Nanette
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention is related to the use of an RAR antagonist for the inhibition of mucin production in a mammal. Preferably the RAR antagonist is an , RAR.alpha. selective antagonist. In another aspect this invention is related , to the inhibition of mucin gene expression in a human epithelial cell by contacting the cell with an RAR antagonist preferably an RAR.alpha. selective , antagonist.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 1, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 1, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 1, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.